Brief: ChromoGenics Q2 Net Sales Rise To SEK 12.5 Million

ChromoGenics AB

28/08/2019 07:35

Aug 28 (Reuters) - ChromoGenics AB  CHRO.ST :
    * INTERIM REPORT JANUARY-JUNE 2019
    * Q2 GROSS PROFIT AMOUNTED TO SEK -1.4 MILLION, WHICH IS AN
IMPROVEMENT OF SEK 4.3 MILLION COMPARED TO CORRESPONDING PERIOD
IN 2018
    * Q2 NET SALES FOR PERIOD AMOUNTED TO SEK 12.5 (2.5) MILLION

Source text for Eikon:  ID:nWkr12lNyk 
Further company coverage:  CHRO.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))